Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade.

Ferrari P, Marti HP, Pfister M, Frey FJ.

J Hypertens. 2002 Jan;20(1):125-30.

PMID:
11791035
2.

Aldosterone antagonists for preventing the progression of chronic kidney disease.

Bolignano D, Palmer SC, Navaneethan SD, Strippoli GF.

Cochrane Database Syst Rev. 2014 Apr 29;(4):CD007004. doi: 10.1002/14651858.CD007004.pub3. Review.

PMID:
24782282
3.

The reno-protective effect of the dual blockade of the renin angiotensin system (RAS).

Luno J, Praga M, de Vinuesa SG.

Curr Pharm Des. 2005;11(10):1291-300. Review.

PMID:
15853685
4.

Aldosterone antagonists for preventing the progression of chronic kidney disease.

Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007004. doi: 10.1002/14651858.CD007004.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;4:CD007004.

PMID:
19588415
5.

Efficacy and safety of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in diabetic nephropathy: a meta-analysis.

Tian ML, Shen Y, Sun ZL, Zha Y.

Int Urol Nephrol. 2015 May;47(5):815-22. doi: 10.1007/s11255-015-0968-2. Epub 2015 Apr 11. Review.

PMID:
25862237
6.

ACEI/ARB therapy for IgA nephropathy: a meta analysis of randomised controlled trials.

Cheng J, Zhang W, Zhang XH, He Q, Tao XJ, Chen JH.

Int J Clin Pract. 2009 Jun;63(6):880-8. doi: 10.1111/j.1742-1241.2009.02038.x. Review.

PMID:
19490198
7.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.

Sharma P, Blackburn RC, Parke CL, McCullough K, Marks A, Black C.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007751. doi: 10.1002/14651858.CD007751.pub2. Review.

PMID:
21975774
8.

Dual blockade of the renin-angiotensin system in the progression of renal disease: the need for more clinical trials.

Fernandez-Juárez G, Barrio V, de Vinuesa SG, Goicoechea M, Praga M, Luño J.

J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S250-4. Review.

9.

Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD.

Am J Kidney Dis. 2006 Jul;48(1):8-20. Review.

PMID:
16797382
10.
11.

Combination therapy an ACE inhibitor and an angiotensin receptor blocker for IgA nephropathy: a meta-analysis.

Cheng J, Zhang X, Tian J, Li Q, Chen J.

Int J Clin Pract. 2012 Oct;66(10):917-23. doi: 10.1111/j.1742-1241.2012.02970.x. Review.

PMID:
22994326
12.

Treatment of diabetic nephropathy with angiotensin II receptor antagonist.

Lewis EJ, Lewis JB.

Clin Exp Nephrol. 2003 Mar;7(1):1-8. Review.

PMID:
14586737
13.

Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both?

Hilgers KF, Dötsch J, Rascher W, Mann JF.

Pediatr Nephrol. 2004 Sep;19(9):956-61. Epub 2004 Jul 22. Review.

PMID:
15278690
14.

Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals.

ARB Trialists Collaboration.

J Hypertens. 2011 Apr;29(4):623-35. doi: 10.1097/HJH.0b013e328344a7de. Review.

PMID:
21358417
15.

How to titrate ACE inhibitors and angiotensin receptor blockers in renal patients: according to blood pressure or proteinuria?

Segura J, Christiansen H, Campo C, Ruilope LM.

Curr Hypertens Rep. 2003 Oct;5(5):426-9. Review.

PMID:
12948436
16.

Angiotensin II Receptor Blockers and Cancer Risk: A Meta-Analysis of Randomized Controlled Trials.

Zhao YT, Li PY, Zhang JQ, Wang L, Yi Z.

Medicine (Baltimore). 2016 May;95(18):e3600. doi: 10.1097/MD.0000000000003600. Review.

17.

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

Ahmed A, Jorna T, Bhandari S.

Nephron. 2016;133(3):147-58. doi: 10.1159/000447068. Epub 2016 Jun 24. Review.

18.

ACE inhibitors and proteinuria.

Gansevoort RT, de Zeeuw D, de Jong PE.

Pharm World Sci. 1996 Dec;18(6):204-10. Review.

PMID:
9010883
19.

Angiotensin antagonists and fish oil for treating IgA nephropathy.

Coppo R, Amore A, Peruzzi L, Mancuso D, Camilla R.

Contrib Nephrol. 2007;157:27-36. Review.

PMID:
17495434

Supplemental Content

Support Center